Abiopharma

🔍 Nair Balan (Director)

Company: Liberty Latin America Ltd. (LILA)

Report Date: 2026-05-08

Detailed Transactions and Holdings:

• Acquired 20,000 shares of Class C Common Shares at $8.0745 per share (Direct)
  Date: 2026-05-08 | Code: P | equity_swap_involved: 0 | shares_owned_after: 3,125,039.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Class C Common Shares (Direct)
  Date: 2026-05-08 | Code: H | nature_of_ownership: By IRA | shares_owned_after: 1,139.00
• Holds 0 shares of Class C Common Shares (Direct)
  Date: 2026-05-08 | Code: H | nature_of_ownership: By 401(k) Plan | shares_owned_after: 21,640.00 | Footnotes: F2

Footnotes:

• F1: The price reflects a weighted average of purchases made at prices ranging from $8.0650 to $8.0800. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, information regarding the number of shares purchased at each separate price.
• F2: The Reporting Person received 2,777 shares contributed by Issuer under its 401(k) Plan as of May 8, 2026.
• REMARKS: The trading symbols for the Issuer's classes of common shares are LILA, LILAB, and LILAK.